CBO projects Sen­ate drug pric­ing bill would cut the de­vel­op­ment of 10 drugs over 30 years

The Con­gres­sion­al Bud­get Of­fice on Fri­day said that Sen­ate De­moc­rats’ pro­pos­al to al­low Medicare to ne­go­ti­ate cer­tain drug prices could low­er the fed­er­al deficit by about $288 bil­lion through 2031, and re­duce drug­mak­ers’ 1,300 to­tal drug ap­provals by about 10 drugs over the next three decades.

That trade-off, part of a larg­er Sen­ate rec­on­cil­i­a­tion pack­age on­ly need­ing a sim­ple ma­jor­i­ty of votes to pass, finds a mid­dle ground among the oth­er re­cent Con­gres­sion­al at­tempts to stem ris­ing drug prices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.